Posted on June 19, 2008 by cartier@bio
Recently, there was an interesting study conducted by PricewaterhouseCoopers, the New England Healthcare Institute, the Massachusetts Life Sciences Center, Xconomy and the Massachusetts Technology Collaborative on the Massachusetts Life Sciences Super Cluster, showing the value of a strong science sector economically. This Super Cluster includes Universities, teaching hospitals, biotechnology, medical device, and pharmaceutical companies. Software, [...]
Filed under: BIO, In the News, SBIR, venture capital | Tagged: biotech, MA, Pricewaterhouse, Study, VC | No Comments »
Posted on June 16, 2008 by cartier@bio
A post on SBIRGA asked the question, “Just how short-sighted is the VC community?” The post discussed a recent analysis by the State Science and Technology Institute (May 28th Digest) of a study conducted by Pricewatershouse’s MoneyTree Report that indicates venture capital companies are making more investments in later stage companies and fewer investments in [...]
Filed under: SBIR, venture capital | Tagged: biotech, capitol hill, MoneyTree, SBIR, SBIRGA, SSTI, venture capital | 1 Comment »
Posted on June 11, 2008 by cartier@bio
The Times-Standard had a great piece over the weekend discussing when and how the Government gives away “free money.” The authors debunk these myths. They also discuss the very real grant process that funds innovative new technologies.
They list and answer these myths:
Myth no. 1: Grants are cash money to start businesses. The government will give [...]
Filed under: SBIR, venture capital | Tagged: business financing, entrepreneurs, SBA, SBIR, startup | No Comments »
Posted on June 4, 2008 by cartier@bio
Kickstarting Startups with SBIRs
Editor’s Letter: Capital Offense
Stemina Biomarker receives $150,000 SBIR grant
Boulder-based OptTek focuses on workforce
Lt. Governor Fisher announces $2.7 million in Third Frontier grants Eight companies awarded research commercialization funds
The NIH Conference Comes to Atlanta
DOE awards SBIR grant to Athena Biotechnologies for R&D into 10% drop in ethanol processing by developing heat-tolerant bacteria
Filed under: In the News, SBIR | Tagged: Athena, Lt. Governor Fisher, NIH, OptTek, SBIR, Stemina | No Comments »
Posted on May 16, 2008 by cartier@bio
Policy
· Federal Grants for Entrepreneurs May Change
· SBIR Funding for VC-Owned Firms
Awards
· Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
· Universal Display Corporation Awarded Phase I SBIR Grant from U.S. Air Force to Design Flexible OLED Display Prototype
· Arkansas nanotechnology company gets $224,000 from EPA to develop “green” lighting
Filed under: In the News, SBIR, venture capital | Tagged: Air Force, Entrepreneur, EPA, Lentigen, SBIR | No Comments »
Posted on May 9, 2008 by cartier@bio
Venture-backed firms deserve SBIR grants
Washington Business Journal
Your article “House opens SBIR awards to VC-owned firms” (May 5-11) does an excellent job of discussing the technical aspects of the bill to reauthorize the Small Business Innovation Research program, but it does not say enough about the real-life opportunities it poses — for companies or for patients. [...]
Filed under: In the News, SBIR | Tagged: Business Journal, Gerald McGarrity, SBIR, vc-owned firms, Virxsys | No Comments »
Posted on May 9, 2008 by cartier@bio
Washington Business Journal
The House passed legislation that would make small businesses majority-owned by venture capital firms eligible for Small Business Innovation Research awards.
Through the SBIR program, 2.5 percent of the outside research budgets of 11 federal agencies — including the Department of Defense and the National Institutes of Health — is allocated for small [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, NIH, SBIR, small business innovation, Washington Business Journal | No Comments »
Posted on May 6, 2008 by cartier@bio
The National Dialogue on Entrepreneurship is following the SBIR Debate:
SBIR Bill Advances
A new proposal to reauthorize and modernize the Small Business Innovation Research (SBIR) program is making fast progress through Congress. Late last month, the House of Representatives overwhelmingly passed H.R. 5819, a bill to reauthorize the SBIR program—which directs federal research funds [...]
Filed under: In the News, SBIR, venture capital | Tagged: Congress, HR 5819, Phase I, SBIR, Technology | No Comments »
Posted on May 2, 2008 by cartier@bio
My name is Mark Leahey, and I am the Executive Director of the Medical Device Manufacturers Association (MDMA). MDMA is a national trade association representing innovative, entrepreneurial medical technology companies across the country. Our mission is to ensure that patients have timely access to the latest advancements in medical technology, most of which are developed [...]
Filed under: Congress, Non Profit, SBIR | Tagged: MDMA, medical technology, Phase I grants, SBIR | No Comments »
Posted on April 29, 2008 by cartier@bio
Alzheimer’s Drug Discovery Foundation
A new way to look at funding
The Alzheimer’s Drug Discovery Foundation (ADDF) raises money and awards grants to academic and biotechnology industry scientists who are conducting drug discovery research for Alzheimer’s Disease, related dementias and cognitive aging.
The way research is funded is evolving and by employing a venture capital model, [...]
Filed under: Finding Cures, SBIR, patient groups, venture capital | Tagged: Allon, Alzheimer's disease, Comentis, Estee Lauder, Fillit, SBIR | No Comments »
cartier@bio
nicoleatbio
